USD 1.35
(4.65%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 37.45 Million USD | -9.76% |
2022 | 41.5 Million USD | 9.07% |
2021 | 38.05 Million USD | 21.07% |
2020 | 31.43 Million USD | 20.13% |
2019 | 26.16 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 7.76 Million USD | -3.83% |
2024 Q1 | 8.07 Million USD | -7.12% |
2023 Q1 | 9.9 Million USD | -7.13% |
2023 FY | 37.45 Million USD | -9.76% |
2023 Q3 | 9.42 Million USD | -0.18% |
2023 Q2 | 9.43 Million USD | -4.71% |
2023 Q4 | 8.69 Million USD | -7.74% |
2022 Q1 | 9.96 Million USD | -6.5% |
2022 Q4 | 10.66 Million USD | 3.87% |
2022 Q3 | 10.26 Million USD | -3.23% |
2022 FY | 41.5 Million USD | 9.07% |
2022 Q2 | 10.6 Million USD | 6.46% |
2021 FY | 38.05 Million USD | 21.07% |
2021 Q4 | 10.65 Million USD | 10.62% |
2021 Q3 | 9.63 Million USD | 2.77% |
2021 Q2 | 9.37 Million USD | 11.81% |
2021 Q1 | 8.38 Million USD | 6.13% |
2020 Q4 | 7.9 Million USD | 5256.3% |
2020 Q3 | -153.23 Thousand USD | -3.02% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | -148.73 Thousand USD | 0.0% |
2020 FY | 31.43 Million USD | 20.13% |
2019 Q3 | - USD | 0.0% |
2019 FY | 26.16 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
CannBioRx Life Sciences Corp. | -105.67 Thousand USD | 35539.792% |
BIMI International Medical Inc. | 1.94 Million USD | -1820.613% |
China Jo-Jo Drugstores, Inc. | 31.1 Million USD | -20.388% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 90.55 Million USD | 58.642% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.55 Million USD | 58.642% |
Leafly Holdings, Inc. | 37.45 Million USD | 0.0% |
LifeMD, Inc. | 126.01 Million USD | 70.28% |
LifeMD, Inc. | 126.01 Million USD | 70.28% |
TRxADE HEALTH, Inc. | 2.59 Million USD | -1341.389% |
PetMed Express, Inc. | 78.64 Million USD | 52.381% |
Walgreens Boots Alliance, Inc. | 26.52 Billion USD | 99.859% |